Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27.8M
-
Number of holders
-
86
-
Total 13F shares, excl. options
-
10.4M
-
Shares change
-
+154K
-
Total reported value, excl. options
-
$168M
-
Value change
-
+$102K
-
Put/Call ratio
-
1.47
-
Number of buys
-
43
-
Number of sells
-
-32
-
Price
-
$16.18
Significant Holders of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) as of Q3 2015
103 filings reported holding AXDX - Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share as of Q3 2015.
Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) has 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.4M shares
of 27.8M outstanding shares and own 37.42% of the company stock.
Largest 10 shareholders include Birchview Capital, LP (2.07M shares), CANNELL PETER B & CO INC (1.02M shares), VANGUARD GROUP INC (865K shares), FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. (757K shares), Miura Global Management, LLC (600K shares), BlackRock Fund Advisors (513K shares), BlackRock Institutional Trust Company, N.A. (507K shares), STATE STREET CORP (351K shares), OBERMEYER WOOD INVESTMENT COUNSEL, LLLP (277K shares), and Nuveen Asset Management, LLC (254K shares).
This table shows the top 86 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.